Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHRT
3126
AH Realty Trust
AHRT
$539M
| $425K | ﹤0.01% |
31,991
-42,218
| -57% | -$566K |
|
3127
Columbus McKinnon
CMCO
$622M
| $425K | ﹤0.01% |
8,810
-14,650
| -62% | -$751K |
|
3128
Laureate Education
LAUR
$5.2B
| $425K | ﹤0.01% |
29,307
-66,444
| -69% | -$939K |
|
3129
Johnson Outdoors
JOUT
$506M
| $424K | ﹤0.01% |
3,500
-3,650
| -51% | -$489K |
|
3130
GrafTech
EAF
$200M
| $423K | ﹤0.01% |
3,651
-5,461
| -60% | -$685K |
|
|
ASLN
3131
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $423K | ﹤0.01% |
3,207
-8
| -0.2% | -$1K |
|
3132
Ameresco
AMRC
$1.48B
| $422K | ﹤0.01% |
6,728
-17,826
| -73% | -$960K |
|
3133
PUT
Bristol-Myers Squibb
BMY
$135B
| $421K | ﹤0.01% |
6,300
| – | – |
|
3134
Euronet Worldwide
EEFT
$2.93B
| $421K | ﹤0.01% |
3,117
-35,348
| -92% | -$5.15M |
|
|
ORC
3135
Orchid Island Capital
ORC
$1.27B
| $421K | ﹤0.01% |
16,236
-137
| -0.8% | -$3.81K |
|
3136
Danaos Corp
DAC
$2.53B
| $419K | ﹤0.01% |
5,462
+1,043
| +24% | +$64.7K |
|
3137
Metallus
MTUS
$897M
| $419K | ﹤0.01% |
29,666
-23,542
| -44% | -$318K |
|
|
CIR
3138
DELISTED
CIRCOR International, Inc
CIR
| $419K | ﹤0.01% |
12,863
-13,474
| -51% | -$477K |
|
|
MCBC
3139
DELISTED
Macatawa Bank Corp
MCBC
| $418K | ﹤0.01% |
47,779
-18,535
| -28% | -$177K |
|
3140
Bionano Genomics
BNGO
$12.9M
| $417K | ﹤0.01% |
95
+91
| +2,275% | +$359K |
|
3141
BlackRock Enhanced Global Dividend Trust
BOE
$682M
| $417K | ﹤0.01% |
31,365
| – | – |
|
|
XRN
3142
Chiron Real Estate Inc
XRN
$465M
| $417K | ﹤0.01% |
5,651
-17,688
| -76% | -$1.28M |
|
3143
iShares MSCI Turkey ETF
TUR
$214M
| $417K | ﹤0.01% |
19,778
-12,578
| -39% | -$290K |
|
3144
Main Street Capital
MAIN
$5.31B
| $416K | ﹤0.01% |
+10,128
| New | +$421K |
|
3145
Universal Insurance Holdings
UVE
$1.23B
| $416K | ﹤0.01% |
30,002
-20,543
| -41% | -$288K |
|
|
NFBK
3146
DELISTED
Northfield Bancorp
NFBK
| $414K | ﹤0.01% |
25,246
-34,064
| -57% | -$561K |
|
|
FLNA
3147
Filana Therapeutics
FLNA
$48.1M
| $414K | ﹤0.01% |
4,841
-22,491
| -82% | -$1.2M |
|
|
PETQ
3148
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $412K | ﹤0.01% |
10,661
-9,122
| -46% | -$364K |
|
3149
Equity Bancshares
EQBK
$1.06B
| $410K | ﹤0.01% |
13,446
-10,155
| -43% | -$311K |
|
3150
Farmers National Banc Corp
FMNB
$947M
| $410K | ﹤0.01% |
26,417
-19,742
| -43% | -$332K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.